We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

103 hedge funds and large institutions have $358M invested in iShares US Pharmaceuticals ETF in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

26.87% more ownership

Funds ownership: 96.2% → 123.06% (+27%)

11% more capital invested

Capital invested by funds: $321M → $358M (+$36.7M)

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

1% more funds holding

Funds holding: 102 → 103 (+1)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

24% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 38

Holders
103
Holders Change
+1
Holders Change %
+0.98%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
16
Increased
29
Reduced
38
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$31.5M
2
LPL Financial
LPL Financial
California
+$10.4M
3
EM
EnTrustPermal Management
New York
+$6.27M
4
Morgan Stanley
Morgan Stanley
New York
+$4.21M
5
UBS Group
UBS Group
Switzerland
+$3.86M

Top Sellers

1
BCM
Brookstone Capital Management
Illinois
-$16.3M
2
BWM
Braver Wealth Management
Massachusetts
-$14.9M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.28M
4
Bank of America
Bank of America
North Carolina
-$3.69M
5
Jane Street
Jane Street
New York
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Avalon Capital Management
California
$2.02M – – –
PP
27
Patten & Patten
Tennessee
$1.77M -$90.7K -1,725 -5%
NPC
28
National Planning Corporation
California
$1.68M -$462K -8,775 -19%
CFA
29
Cahill Financial Advisors
Minnesota
$1.5M -$105K -1,992 -7%
CPC
30
Cookson Peirce & Co
Pennsylvania
$1.43M -$17.4K -330 -1%
SI
31
SII Investments
Wisconsin
$1.32M -$28.4K -540 -2%
WA
32
WESPAC Advisors
California
$1.28M +$1.25M +23,709 New
Citadel Advisors
33
Citadel Advisors
Florida
$1.23M -$1.95M -37,074 -62%
KCM
34
Karp Capital Management
California
$1.22M -$523K -9,945 -31%
JP Morgan Chase
35
JP Morgan Chase
New York
$1.2M -$218K -4,143 -16%
ICOA
36
Investment Centers of America
North Dakota
$1.17M -$21.6K -411 -2%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$1.09M -$1.2M -22,752 -53%
Envestnet Asset Management
38
Envestnet Asset Management
Illinois
$1.06M -$3.41M -64,803 -77%
AMG
39
Asset Management Group
Connecticut
$1.04M +$2.52K +48 +0.2%
Koshinski Asset Management
40
Koshinski Asset Management
Illinois
$969K +$2.52K +48 +0.3%
HH
41
Hilltop Holdings
Texas
$864K – – –
CIBC World Market
42
CIBC World Market
Ontario, Canada
$722K -$768K -14,607 -52%
Ameriprise
43
Ameriprise
Minnesota
$716K -$98.3K -1,869 -12%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$710K +$20.7K +393 +3%
US Bancorp
45
US Bancorp
Minnesota
$701K -$3.16K -60 -0.5%
LTFS
46
Ladenburg Thalmann Financial Services
Florida
$697K -$2.55M -48,378 -79%
MLIC
47
Mandatum Life Insurance Company
Finland
$690K +$674K +12,816 New
TYCC
48
Texas Yale Capital Corp
Florida
$602K – – –
PAG
49
Pinnacle Advisory Group
Maryland
$555K – – –
CLOS
50
Compagnie Lombard Odier SCmA
Switzerland
$552K – – –
1
2
3 4 5

IHE Hedge Fund Activity: Q4 2015 in Review

103 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2015, worth a combined $358M — up 11% from $321M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IHE positions and 15 closed out — a net gain of 1 holder — while 29 added to existing stakes and 38 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $31.5M. The largest seller was Brookstone Capital Management, exiting entirely with an estimated $16.3M sold.

  • 103 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2015, up from 102 in Q3 2015.
  • Funds reported $358M of iShares US Pharmaceuticals ETF stock for Q4 2015, up 11% quarter-over-quarter.
  • 16 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2015 and 15 closed out, a net change of +1 holder.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2015 was Goldman Sachs, an estimated $31.5M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2015 was Brookstone Capital Management, an estimated $16.3M sold.

Based on aggregated 13F filings for Q4 2015.